Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease.
Kogel AK, Ladopoulos T, Schwake C, Kleiter I, Teegen B, Siems N, Prehn C, Lichtenberg S, Ringelstein M, Aktas O, Pul R, Krieger B, Lukas C, Penner IK, Gold R, Schneider R, Ayzenberg I. Kogel AK, et al. Among authors: schwake c. Neurol Neuroimmunol Neuroinflamm. 2024 Dec;11(6):e200325. doi: 10.1212/NXI.0000000000200325. Epub 2024 Oct 11. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39393044 Free article.
Endocarditis following ocrelizumab in relapsing-remitting MS.
Faissner S, Schwake C, Gotzmann M, Mügge A, Schmidt S, Gold R. Faissner S, et al. Among authors: schwake c. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 3;7(3):e680. doi: 10.1212/NXI.0000000000000680. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32014890 Free PMC article. No abstract available.
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
Havla J, Pakeerathan T, Schwake C, Bennett JL, Kleiter I, Felipe-Rucián A, Joachim SC, Lotz-Havla AS, Kümpfel T, Krumbholz M, Wendel EM, Reindl M, Thiels C, Lücke T, Hellwig K, Gold R, Rostasy K, Ayzenberg I. Havla J, et al. Among authors: schwake c. J Neuroinflammation. 2021 May 29;18(1):121. doi: 10.1186/s12974-021-02160-9. J Neuroinflammation. 2021. PMID: 34051804 Free PMC article.
Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.
Fels M, Fisse AL, Schwake C, Motte J, Athanasopoulos D, Grüter T, Spenner M, Breuer T, Starz K, Heinrich D, Grond M, Keyvani K, Appeltshauser L, Doppler K, Sommer C, Ayzenberg I, Schneider-Gold C, Gold R, Pitarokoili K, Labedi A. Fels M, et al. Among authors: schwake c. J Peripher Nerv Syst. 2021 Dec;26(4):475-480. doi: 10.1111/jns.12465. Epub 2021 Sep 7. J Peripher Nerv Syst. 2021. PMID: 34486194
Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.
Pakeerathan T, Havla J, Schwake C, Salmen A, Bigi S, Abegg M, Brügger D, Ferrazzini T, Runge AK, Breu M, Kornek B, Bsteh G, Felipe-Rucián A, Ringelstein M, Aktas O, Karenfort M, Wendel E, Kleiter I, Hellwig K, Kümpfel T, Thiels C, Lücke T, Gold R, Rostasy K, Ayzenberg I. Pakeerathan T, et al. Among authors: schwake c. J Neurol. 2022 Dec;269(12):6366-6376. doi: 10.1007/s00415-022-11256-y. Epub 2022 Jul 23. J Neurol. 2022. PMID: 35869995 Free PMC article.
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study.
Carta S, Cobo Calvo Á, Armangué T, Saiz A, Lechner C, Rostásy K, Breu M, Baumann M, Höftberger R, Ayzenberg I, Schwake C, Sepulveda M, Martínez-Hernández E, Olivé-Cirera G, Arrambide G, Tintoré M, Bernard-Valnet R, Du Pasquier R, Brilot F, Ramanathan S, Schanda K, Gajofatto A, Ferrari S, Sechi E, Flanagan EP, Pittock SJ, Redenbaugh V, Reindl M, Marignier R, Mariotto S. Carta S, et al. Among authors: schwake c. Neurology. 2023 Mar 14;100(11):e1095-e1108. doi: 10.1212/WNL.0000000000201662. Epub 2022 Dec 16. Neurology. 2023. PMID: 36526426 Free PMC article.
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies.
Schwake C, Pakeerathan T, Kleiter I, Ringelstein M, Aktas O, Korporal-Kuhnke M, Wildemann B, Jarius S, Bayas A, Pul R, Ceylan U, Faissner S, Hellwig K, Ayroza Galvao Ribeiro Gomes AB, Lipps P, Pröbstel AK, Kümpfel T, Oswald E, Then Bergh F, Gödel C, Hümmert MW, Trebst C, Gold R, Ayzenberg I. Schwake C, et al. Mult Scler. 2023 May;29(6):757-761. doi: 10.1177/13524585221151124. Epub 2023 Feb 7. Mult Scler. 2023. PMID: 36748649 Free PMC article.
42 results